招银证券 ：
［维持爱康医疗(01789) “买入”评级 ，唯目标价由上月的12.14元降至9.62港元］
招银将爱康医疗的21/22E/23E财年归属净利润预测下调了15%/21%/27%。。。
<< Results of volume-based procurement to come out in mid-September >>
2021-08-26 00:00 机构：招银证券 分析师：Jill Wu
Maintain BUY. We trimmed our FY21/22E/23E attributable net profit forecasts by 15%/ 21%/ 27% to reflect the potential impact from national VBP. We cut our DCF-based TP from HK$12.14 to HK$9.62 (WACC 10.0%, Terminal growth 3.0%). We believe the Company will resume solid growth after FY22E thanks to its comprehensive product portfolio and strong innovation capability.
OK！